ResMed Inc. (RMD) NYSE
230.84
-1.57(-0.68%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
230.84
-1.57(-0.68%)
Currency In USD
| Market Cap | 37.85B |
| Enterprise Value | 37.5B |
| P/E Ratio | 22.76 |
| PEG Ratio | 6.57 |
| Price/Sales Ratio | 6.24 |
| Price/Book Ratio | 5.35 |
| Enterprise/Revenue | 6.17 |
| Enterprise/EBITDA | 16.06 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.28 |
| Operating Margin | 0.34 |
| Return On Assets | 0.17 |
| Return On Equity | 0.25 |
| Revenue | 5.15B |
| Revenue/Share | 36.85 |
| Gross Profit | 3.05B |
| EBITDA | 1.91B |
| Net Income | 1.4B |
| Diluted EPS | 9.51 |
| Total Cash | 1.43B |
| Total Cash/Share | 9.74 |
| Total Debt | 1B |
| Total Debt/Equity | 0.16 |
| Current Ratio | 3.06 |
| Book Value Per Share | 43.15 |
| 52-Week Change | 2.98 |
| 52-Week High | 293.81 |
| 52-Week Low | 199.92 |
| Moving Average 50 Days | 254.78 |
| Moving Average 200 Days | 260.64 |
| Average Volume | 1.07M |
| Shares Outstanding | 145.97M |
| % Held by Institutions | 66.16 |
| Trailing Annual Dividend Rate | 2.33 |
| Trailing Annual Dividend Yield | 1.01 |
| Payout Ratio | 0.22 |
| Last Split Factor | 2:1 |
| Last Split Date | August 31, 2010 |